Cobalt, linac, or other: What is the best solution for radiation therapy in developing countries?

Brandi R. Page, Alana D. Hudson, Derek W. Brown, Adam C. Shulman, May Abdel-Wahab, Brandon J. Fisher, Shilpen Patel

Research output: Contribution to journalArticlepeer-review

Abstract

The international growth of cancer and lack of available treatment is en route to become a global crisis. With >60% of cancer patients needing radiation therapy at some point during their treatment course, the lack of available facilities and treatment programs worldwide is extremely problematic. The number of deaths from treatable cancers is projected to increase to 11.5 million deaths in 2030 because the international population is aging and growing. In this review, we present how best to answer the need for radiation therapy facilities from a technical standpoint. Specifically, we examine whether cobalt teletherapy machines or megavoltage linear accelerator machines are best equipped to handle the multitudes in need of radiation therapy treatment in the developing world.

Original languageEnglish (US)
Pages (from-to)476-480
Number of pages5
JournalInternational Journal of Radiation Oncology Biology Physics
Volume89
Issue number3
DOIs
StatePublished - Jul 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'Cobalt, linac, or other: What is the best solution for radiation therapy in developing countries?'. Together they form a unique fingerprint.

Cite this